Clinical management of hereditary angio-oedema in children

Pediatric Allergy and Immunology

Volumn 13, Issue 3, 2002, Pages 153-161

  Farkas, Henriette ^a   Harmat, George ^b   Füst, George ^c   Varga, Lilian ^d   Visy, Beáta ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Madarasz Children's Hospital   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d National Institute of Haematology and Immunology Budapest   (Hungary)

Author keywords

C1 esterase inhibitor concentrate; Children; Danazol; Hereditary angio oedema; Tranexamic acid

Indexed keywords

BERINERT P; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; DANOVAL; TRANEXAMIC ACID; AMINOCAPROIC ACID;

ADOLESCENT; ANGIONEUROTIC EDEMA; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MENARCHE; MENSTRUATION DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SKIN EDEMA; SUBCUTANEOUS TISSUE; ULTRASOUND; GENETICS; IMMUNOLOGY; INFANT; PRESCHOOL CHILD;

6-AMINOCAPROIC ACID; ADOLESCENT; ANGIONEUROTIC EDEMA; CHILD; CHILD, PRESCHOOL; COMPLEMENT 1 INACTIVATORS; DANAZOL; FEMALE; HUMAN; INFANT; MALE; TRANEXAMIC ACID; COMPLEMENT C1 INACTIVATOR PROTEINS; HUMANS;

EID: 0036023680     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2002.01014.x     Document Type: Review

References (30)

1. A biochemical abnormality in hereditary angioneurotic oedema. Absence of serum inhibitor of C1-esteras
2. Complement in the pathophysiology of human disease
3. Hereditary amd acquired C1-inhibitor deficiency: Biological and chemical characteristics in 235 patients
4. Human C1 inhibitor: Primary structure, cDNA cloning and chromosomal localization
5. Hereditary angioneurotic oedema: Two genetic variants
6. Activation of the complement, coagulation, fibrinolytic and kallikrein systems during attacks of hereditary angio-oedema
7. Hereditary angioedema: The clinical syndrome and its management
8. Hereditary angio-oedema; an infrequent cause of abdominal pain with ascites
9. Treatment of hereditary angio-oedema with a vapor-heated C1 inhibitor concentrate
10. Replacement therapy in hereditary angio-oedema: Successful treatment of two patients with fresh frozen plazma
11. C1 inhibitor and diagnosis of hereditary angio-oedema in new-borns
12. Methyltestosterone therapy for hereditary episodic oedema
13. Treatment of hereditary angio-oedema with danazol: Reversal of clinical and biochemical abnormalities
14. Epsilon aminocaproic acid therapy of hereditary angioneurotic oedema: A double-blind study
15. Long term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angio-oedema caused by hereditary and acquired C1-inhibitor deficiency
16. Complement and complement fixation
17. Immunochemical quantitation of the third, fourth, and fifth components of human complement: Concentration in the sera of healthy adults
18. Hereditary angio-oedema
19. Recurrent abdominal pain as the sole manifestation of hereditary angiooedema in multiple family members
20. Sonographic findings in abdominal hereditary angio-oedema
21. Danazol therapy for hereditary angio-oedema in children
22. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the prod-uction of C1-inhibitor concentrate
23. Hereditary angio-oedema: Danazol therapy in a 5-year old child
24. Danazol and stanozolol in long-term prophylactic treatment of hereditary angio-oedema
25. Danazol for children with immune thrombocytopenic purpura
26. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients
27. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema
28. The efficacy of short-term danazol prophylaxis in hereditary angiooedema patients undergoing maxillo-facial and dental procedures
29. Hereditary angio-oedema in children
30. Tonsillectomy in a patient with hereditary angio-oedema after prophylaxis with C1 inhibitor concentrate